Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for myocardial protection during elderly thoracic surgery
ChiCTR-IPR-17010612Phase 4Recruiting
- Sponsor
- Capital Medical University
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in bronchial carcinoma (2 arms), sponsored by Capital Medical University. Primary endpoint: Troponin I. Started Feb 2017; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR-IPR-17010612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010612.